Cargando…
Targeting Tumor-Associated Macrophages in Anti-Cancer Therapies: Convincing the Traitors to Do the Right Thing
In the last decade, it has been well-established that tumor-infiltrating myeloid cells fuel not only the process of carcinogenesis through cancer-related inflammation mechanisms, but also tumor progression, invasion, and metastasis. In particular, tumor-associated macrophages (TAMs) are the most abu...
Autores principales: | Belgiovine, Cristina, Digifico, Elisabeth, Anfray, Clément, Ummarino, Aldo, Torres Andón, Fernando |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600332/ https://www.ncbi.nlm.nih.gov/pubmed/33050070 http://dx.doi.org/10.3390/jcm9103226 |
Ejemplares similares
-
Current Strategies to Target Tumor-Associated-Macrophages to Improve Anti-Tumor Immune Responses
por: Anfray, Clément, et al.
Publicado: (2019) -
Macrophages and cancer stem cells: a malevolent alliance
por: Allavena, Paola, et al.
Publicado: (2021) -
Intratumoral combination therapy with poly(I:C) and resiquimod synergistically triggers tumor-associated macrophages for effective systemic antitumoral immunity
por: Anfray, Clément, et al.
Publicado: (2021) -
TAMeless traitors: macrophages in cancer progression and metastasis
por: Aras, Shweta, et al.
Publicado: (2017) -
Innate and Adaptive Responses of Intratumoral Immunotherapy with Endosomal Toll-Like Receptor Agonists
por: Andón, Fernando Torres, et al.
Publicado: (2022)